Cardiopathology in Methamphetamine Poisoning-Related Deaths in Chiang Mai Thailand
DOI:
https://doi.org/10.37506/2cya1962Keywords:
Methamphetamine, Amphetamine, heart pathology, Arteriosclerosis, Blood Methamphetamine level.Abstract
Background: Blood Methamphetamine levels have been utilized to assess methamphetamine exposure and its toxicity. Heart is a major target organ of methamphetamine intoxication. In some autopsy cases heart pathologies have been revealed at low level of methamphetamine and extensively to be understand a relationship between the blood methamphetamine level and heart pathology.
Aim: The aim of this study was to assess the relationship between blood methamphetamine level and heart pathology by using postmortem cases.
Methodology: One hundred and twenty medico-legal cases were included and blood methamphetamine or amphetamine levels in whole blood along with heart pathological finding were determined.
Results: Coronary atherosclerosis, myocardial fiber hypertrophy, and fibrosis of the left ventricular myocardium were highly frequency findings in methamphetamine intoxication. Interestingly, forensic cases revealed myocardial fiber hypertrophy in chronic methamphetamine users.
Conclusion: The levels of methamphetamine and amphetamine associated with myocarditis, cardiomyopathy and dystrophic calcification mitral valve. Evaluation of methamphetamine and amphetamine levels are key biomarkers for predicting the seriousness of heart-related pathological conditions.
References
Miller DR, Bu M, Gopinath A,Martinez LR, Khoshbouei H. Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity. J Pharmacol Exp Ther. 2021; 379(3): 372-385.
Edinoff AN, Kaufman SE, Green KM, Provenzano DA, Lawson J, CornettEM, Murnane KS, Kaye AM, Kaye AD.Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities. Health Psychol Res. 2022; 10(3): 38161.
Kevil CG, Goeders N,Wollard MD, Bhuiyan MS, Dominic P, Kolluru GK, Arnold CL, Arnold CL, Traylor JG, Orr AW. Methamphetamine Use and Cardiovascular Disease. ArteriosclerThrombVasc Biol. 2019: 39(9): 1739-1746.
Latif A, Ahsan MJ, Lateef N, Kapoor V, Lundgren S, Ahsan MZ, Ahmad S, Mirza M. Is Methamphetamine-Linked Cardiomyopathy an Emerging Epidemic for New Generation?.Curr ProblCardiol. 2023;48(1): 101042.
Curran L, Nah G, Marcus GM, Tseng Z,Crawford MH, Parikh NI. Clinical Correlates and Outcomes of Methamphetamine-Associated Cardiovascular Diseases in Hospitalized Patients in California.J Am Heart Assoc. 2022; 11(16): e023663.
Tobolski J, Sawyer DB, Song SJ, Afari ME. Cardiovascular disease associated with methamphetamine use: a review. Heart Failure Reviews. 2022; 27(6): 2059-2065.
Schwarzbach V, Lenk K, Laufs U.Methamphetamine-related cardiovascular diseases. ESC Heart Failure. 2020;7(2): 407-414.
Bruno VD, Duggan S, Capoun R, Ascione R.Methamphetamine-induced cardiomyopathy causing severe mitralvalve regurgitation. Arch Med Sci. 2014; 10: 630-631
SniderJC, Riley LA, Mallory NT, Bersi MR, Umbarkar P, Gautam R, Zhang Q, Jansen AM, Hatzopoulos A, Maroteaux L, Lal H, Merryman WD. Targeting 5-ht2b receptor signaling prevents border zone expansion and improves microstructural remodeling after myocardial infarction. Circulation. 2021 143: 1317–1330.
DePriest AZ, Puet BL, Holt AC, Roberts A, Cone EJ. Metabolism and Disposition of Prescription Opioids: A Review. Forensic Sci Rev. 2015;27:115–145.
Chaichana J, Khamenkhetkarn M, Sastraruji T,Monum T, O’ BrienTE, Amornlertwatana Y, Jaikang C.Categorization of Cytochrome P4502D6 Activity Score by Urinary Amphetamine/Methamphetamine Ratios.Metabolites. 2022;12(12): 1174.
Shima N, Kamata HT,Katagi M, Tsuchihashi H. Urinary excretion of the main metabolites of methamphetamine, including p-hydroxymethamphetamine-sulfate and p-hydroxymethamphetamine-glucuronide, in humans and rats.Xenobiotica, 2006; 36 (2-3): 259-267.
Sutter ME, Gaedigk A, Albertson TE, Southard J,Owen KP,Mills LD,Diercks DB. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure. Clin Toxicol. 2013; 51(7): 540-544.
Nakashima K. High-Performance Liquid Chromatographic Analysis of Drugs of Abuse in Biologic Samples. J Health Sci. 2005;51(3): 272-277.
Dostalek M, Jurica J,Pistovcakova J, Hanesova M.Effect of methamphetamine on cytochrome P450 activity. Xenobiotica. 2008; 37(12): 1355-1366.
Kiyatkin EA, Sharma HS. Acute methamphetamine intoxication: brain hyperthermia, blood-brain barrier, brain edema, and morphological cell abnormalities. Int Rev Neurobiol. 2009; 88: 65-100.
PhuangphungP, Wongchanapai W.The Study of Pathological Findings in MedicoLegal Cases Positive for Urinary Methamphetamine in Thai Postmortem Cases. Vajira Medical Journal: Journal of Urban Medicine. 2023; 67(1), 439-447.
J.S. Kays, B.K. Yamamoto. Evaluation of Microglia/Macrophage Cells from Rat Striatum and Prefrontal Cortex Reveals Differential Expression of Inflammatory-Related mRNA after Methamphetamine. Brain Sci. 2019; 9(12): 340.
Akhgari M, Mobaraki H, Etemadi-Aleagha A.Histopathological study of cardiac lesions in methamphetamine poisoning-related deaths. Daru. 2017; 25(1): 5.
ChernerM, Bousman C, Everall I, Barran D, Letendre S, Vaida F, Atkinson JK, Heaton R, Grant I, The HNRC Group.Cytochrome P450-2D6extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: Preliminary findings. J inter Neuropsychol Soc.2010; 16(5), 890-901.
Zhang C, Chen C, Xhao X, Lu J, Zhang M, Qiu H, Yue X, Wang H.New insight into methamphetamine-associated heart failure revealed by transcriptomic analyses: Circadian rhythm disorder. Toxicol Appl Pharmacol. 2022; 451: 116172.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Prompiriya Jatuten, Tawachai Monum, Yutti Amornlertwatana, Churdsak Jaikang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en